Completed NA INTERVENTIONAL 2-arm NCT01054560

SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study (SWIFT)

Sponsor: Medtronic Neurovascular Clinical Affairs

Interventions MERCI® Device SOLITAIRE™ Device

Updated 6 times since 2017 Last updated: Aug 31, 2016 Started: Jan 31, 2010 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Ischemic Stroke and is currently completed. Medtronic Neurovascular Clinical Affairs leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Neurovascular Clinical Affairs

Data source: Medtronic Neurovascular Clinical Affairs

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States
• Tacoma, United States